ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Zeo ScientifiX, Inc.
Financials through Q2 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 15, 2026
$0.91+0.00 (+0.15%)
Close on Oct 19, 2026
- Market cap
- $7.08M
- P/E (TTM)
- –
- Dividend yield
- –
Zeo ScientifiX, Inc. revenue by segment
By business segment
| Revenue | Q4 18 | Q3 18 | Q2 18 | Q1 18 | Q4 17 | Q3 17 | Q2 17 | Q1 17 | Q4 16 | Q3 16 | Q2 16 | Q1 16 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient Referral and Product Sales [Member] | $248.14K | $92.56K | $92.56K | $417.36K | $262.62K | $140.01K | $140.01K | $585 | $31.88K | $24.71K | $66.70K | – | 100.0% | -5.5% |
| MMTC Activities [Member] | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | – | – | – | – | 0.0% | – |
| Clothing Sales [Member] | – | – | – | – | – | – | – | – | – | $1.42K | $38.66K | $28.57K | – | – |
| Patient Referrals and Product Sales [Member] | – | – | – | – | – | – | – | – | – | $24.71K | $66.70K | $61.60K | – | – |
| Operating Segment [Member] | – | – | – | – | – | – | – | – | – | $26.13K | $105.36K | – | – | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Zeo ScientifiX's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.